Genentech lists Phase Ib KRAS G12D trial; Roche-sponsored DLBCL study shows updateOct 9Weekly roundup, 9 itemsalectinibcisplatinUpdated
Genentech gets two ROZLYTREK label updates; Roche's IMvigor011, forimtamig results standOct 2Weekly roundup, 13 itemsafimkibartatezolizumabUpdated